DE LEO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 9.740
NA - Nord America 7.332
EU - Europa 5.918
AF - Africa 616
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 463
OC - Oceania 14
Totale 24.622
Nazione #
US - Stati Uniti d'America 7.106
VN - Vietnam 3.156
IT - Italia 2.838
SG - Singapore 2.292
CN - Cina 2.104
HK - Hong Kong 596
DE - Germania 524
SE - Svezia 441
BR - Brasile 403
GB - Regno Unito 392
KR - Corea 329
NL - Olanda 327
IN - India 311
BD - Bangladesh 293
FR - Francia 268
FI - Finlandia 187
CI - Costa d'Avorio 181
IE - Irlanda 177
RU - Federazione Russa 156
JP - Giappone 141
CA - Canada 140
SC - Seychelles 137
TG - Togo 117
CH - Svizzera 116
AT - Austria 83
ID - Indonesia 83
PH - Filippine 75
PL - Polonia 75
JO - Giordania 72
ZA - Sudafrica 67
BG - Bulgaria 61
AR - Argentina 56
ES - Italia 52
NG - Nigeria 44
IQ - Iraq 42
PK - Pakistan 40
TH - Thailandia 39
TR - Turchia 38
UA - Ucraina 33
MX - Messico 30
TW - Taiwan 30
BE - Belgio 26
SK - Slovacchia (Repubblica Slovacca) 21
JM - Giamaica 20
EC - Ecuador 19
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
DZ - Algeria 16
IR - Iran 16
LT - Lituania 16
UZ - Uzbekistan 15
VE - Venezuela 15
CL - Cile 14
CO - Colombia 14
GR - Grecia 14
AU - Australia 13
MK - Macedonia 13
EE - Estonia 12
KE - Kenya 9
DK - Danimarca 8
HR - Croazia 8
MY - Malesia 8
NO - Norvegia 8
PT - Portogallo 8
RO - Romania 8
CR - Costa Rica 7
OM - Oman 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
RS - Serbia 5
TN - Tunisia 5
AO - Angola 4
EG - Egitto 4
GH - Ghana 4
TT - Trinidad e Tobago 4
UG - Uganda 4
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
LV - Lettonia 3
ML - Mali 3
NP - Nepal 3
SI - Slovenia 3
UY - Uruguay 3
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 24.124
Città #
Singapore 1.584
Ashburn 1.058
Ho Chi Minh City 892
Bologna 848
Hanoi 721
Hefei 651
San Jose 555
Hong Kong 554
Chandler 379
Council Bluffs 314
Seoul 301
Santa Clara 300
Dallas 297
Southend 256
Beijing 234
Los Angeles 221
Fairfield 205
Milan 203
New York 194
Boardman 191
Abidjan 181
Dublin 173
Helsinki 140
Princeton 140
Da Nang 133
Tokyo 121
Lauterbourg 117
Lomé 117
Seattle 114
Houston 112
Redmond 112
Haiphong 109
Bern 102
Rome 96
Rimini 94
Turin 85
Wilmington 84
Woodbridge 82
Buffalo 75
Frankfurt am Main 75
Amman 72
São Paulo 68
Warsaw 66
Munich 65
Florence 62
Amsterdam 61
Sofia 61
Bengaluru 59
Cambridge 59
Vienna 58
Redondo Beach 57
Chicago 52
Jakarta 52
Berlin 50
Hyderabad 45
Montreal 45
Groningen 42
Guangzhou 42
Thái Nguyên 42
Shanghai 41
Ann Arbor 40
Atlanta 40
Biên Hòa 40
Hải Dương 40
Orem 40
Johannesburg 38
Quận Bình Thạnh 38
Abeokuta 37
Denver 37
London 36
Modena 36
Nuremberg 36
Can Tho 35
Naples 33
Toronto 33
Bremen 32
Phoenix 31
Des Moines 30
Dong Ket 30
Hangzhou 30
Lappeenranta 30
San Francisco 30
Brooklyn 29
Ninh Bình 29
San Diego 29
Bến Tre 28
Shenzhen 27
The Dalles 27
Verona 27
Falkenstein 26
Vũng Tàu 26
Ha Long 25
Phủ Lý 24
Thái Bình 24
Forlì 23
Westminster 23
Nanjing 22
Nha Trang 22
Paris 22
Ravenna 22
Totale 14.546
Nome #
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 642
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 440
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 369
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 348
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 338
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 320
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 307
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 300
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review 290
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 278
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 272
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 267
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 265
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 264
An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. A multidisciplinary approach 262
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 253
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 249
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 248
Next-generation technologies in predictive molecular pathology of lung cancers 246
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 241
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 241
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 240
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 239
Classification systems of endometrial cancer: A comparative study about old and new 237
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 234
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 234
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 231
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers 215
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma 214
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 214
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment 214
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 213
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 213
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 211
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation. 209
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 204
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy 202
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 200
Relevance of ARID1A Mutations in Endometrial Carcinomas 200
Can we improve the diagnosis of invasion in encapsulated follicular-patterned thyroid tumors? Data from a massive international e-learning initiative 200
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 199
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients 198
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 198
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 197
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 194
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms 193
Robbins e Cotran Le basi patologiche delle malattie. Capitolo 23 ''La mammella''. 191
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 190
Analysis of HNF1β expression suggests that its downregulation is involved in the sarcomatoid transformation of yolk sac tumor 188
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 182
Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients 180
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 179
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma 178
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 176
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 173
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 172
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 171
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 171
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas 170
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 169
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 167
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 167
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 167
Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity 163
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 160
An exceptional case of primary ovarian angiosarcoma 160
DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas 159
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes 159
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel 154
Uterine preservation treatments in sarcomas: Oncological problems and reproductive results: A systematic review 152
Characterization of BRCA Deficiency in Ovarian Cancer 151
Integrated clinicopathological and molecular analysis of endometrial carcinoma: prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification 149
Endometriosis-Associated Ovarian Carcinomas: Histotypes and Molecular Profiling 148
Gene expression landscape of sdh-deficient gastrointestinal stromal tumors 148
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 147
Prognostic Evaluation of Localized Primary Gastrointestinal Stromal Tumors (GIST): Comparison between Risk Classification Systems and Role of Mutational Analysis in a Single Unit Experience 147
A Radiomic-Based Machine Learning Model Predicts Endometrial Cancer Recurrence Using Preoperative CT Radiomic Features: A Pilot Study 147
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 145
Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis 144
Granular cell tumour of the breast: A rare presentation of a breast mass in an elderly female with a subsequent breast cancer diagnosis 143
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 141
Radiomics and artificial intelligence in uterine sarcomas: A systematic review 139
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST 136
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 133
Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma? 132
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel 132
Endometrial carcinoma: Past, present, and future 128
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 127
Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas. 127
Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter 127
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance 126
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 126
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel 125
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study 122
Diagnostic Feasibility and Accuracy of Endoscopic Ultrasound-Guided Fine Needle Core Biopsy (EUS-FNB): A Single-Center Large Cohort Study 115
Molecular alterations in pancreatic tumors 115
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region 115
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 7: Pd-l1 expression in liquid biopsy 114
Performance and clinical utility of two targeted multigene panels for GIST molecular characterization 114
CORRELATION BETWEEN CLINICAL (Cl-R) AND PATHOLOGICAL RESPONSE (Pt-R) AFTER NEO-ADJUVANT ELECTROCHEMOTHERAPY (ECT) IN VULVAR SQUAMOUS CELL CARCINOMA(V-SCC) 113
Totale 19.817
Categoria #
all - tutte 68.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.318 0 30 47 96 131 78 39 136 111 112 349 189
2022/20232.566 150 251 152 259 203 221 89 167 469 109 224 272
2023/20241.105 111 109 59 91 106 184 60 86 62 78 55 104
2024/20254.165 267 408 370 288 468 205 315 191 104 348 384 817
2025/202613.119 1.856 1.194 1.089 923 892 478 1.455 356 2.222 936 1.111 607
2026/2027824 414 410 0 0 0 0 0 0 0 0 0 0
Totale 24.622